معرفی
Dr. Brooke Nickel is an NHMRC Emerging Leader Research Fellow at the Sydney School of Public Health, The University of Sydney. She leads research in evidence-based healthcare communication, medical decision-making, and overdiagnosis, with a focus on breast cancer, thyroid cancer, and health literacy. Her work explores psychosocial impacts of cancer diagnosis, equity in screening practices, and social media health marketing.
Education
- BSc Hons, Wilfrid Laurier University (2010)
- MIPH, The University of Sydney (2012)
- PhD in Medicine, The University of Sydney (2018)
Research Themes
Dr. Nickel's research bridges public health, cancer communication, and health psychology. She investigates how breast density notification affects screening adherence, AI in cancer screening, and equitable healthcare practices for culturally diverse populations. Her work on relabeling low-risk cancers (e.g., melanoma in situ, DCIS) informs clinical guidelines and patient-centered care.
Recent article trends show expertise in health communication, screening program evaluation, and social determinants of cancer outcomes. She analyzes digital health tools, PREMs, and telehealth impacts during the pandemic.
Scientific Awards
- 2025 EMCR Outstanding Publication Award
- 2025 Talented Researcher Award
- 2024 Top 2% of Scientists (Stanford/Elsevier)
- 2023 Lisa M Schwartz Prize
- 2022 National Publication Award
- 2019 Peter Bancroft Prize
Grants
Current grants include Sydney Health Partners Implementation Science Grant (2024) for equitable breast density notification and National Breast Cancer Foundation funding (2023) for AI in breast cancer screening. Past grants cover Medibank Health Research Fund (2022) and NHMRC Investigator Grant (2020).
